These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12418538)

  • 1. Competition Commission inquiry into POMs.
    Wormald J
    Vet Rec; 2002 Oct; 151(16):487-8. PubMed ID: 12418538
    [No Abstract]   [Full Text] [Related]  

  • 2. Competition Commission inquiry into POMs.
    Lobb RP
    Vet Rec; 2002 Dec; 151(24):744. PubMed ID: 12509083
    [No Abstract]   [Full Text] [Related]  

  • 3. Competition Commission inquiry into POMs.
    Clark S
    Vet Rec; 2002 Nov; 151(20):616. PubMed ID: 12463542
    [No Abstract]   [Full Text] [Related]  

  • 4. Competition Commission inquiry into Poms.
    Robinson A
    Vet Rec; 2002 Nov; 151(19):582-3. PubMed ID: 12452361
    [No Abstract]   [Full Text] [Related]  

  • 5. Competition Commission recommendations: plans for implementation.
    Vet Rec; 2005 Sep; 157(11):302-3. PubMed ID: 16155233
    [No Abstract]   [Full Text] [Related]  

  • 6. RCVS sets out its concerns on the DTI's proposals on the supply of POMs.
    Vet Rec; 2005 May; 156(22):690. PubMed ID: 15923545
    [No Abstract]   [Full Text] [Related]  

  • 7. VAT on veterinary prescriptions.
    Lawton MP
    Vet Rec; 2005 Oct; 157(15):456; discussion 456. PubMed ID: 16215256
    [No Abstract]   [Full Text] [Related]  

  • 8. Supply of POMs.
    Muckle AP
    Vet Rec; 2003 May; 152(22):695-6. PubMed ID: 12803401
    [No Abstract]   [Full Text] [Related]  

  • 9. Competition Commission inquiry into POMs.
    Atkinson O
    Vet Rec; 2002 Oct; 151(15):456. PubMed ID: 12408335
    [No Abstract]   [Full Text] [Related]  

  • 10. Competition Commission inquiry into POMs.
    Ellis RN
    Vet Rec; 2002 Oct; 151(15):456. PubMed ID: 12408336
    [No Abstract]   [Full Text] [Related]  

  • 11. Competition Commission inquiry into POMs.
    Roger PA; Phillips RH; Richardson LJ; Wann GA; Brannan H
    Vet Rec; 2002 Nov; 151(22):679-80. PubMed ID: 12498416
    [No Abstract]   [Full Text] [Related]  

  • 12. Competition Commission inquiry into POMs.
    Hopkins N
    Vet Rec; 2002 Nov; 151(22):679. PubMed ID: 12498415
    [No Abstract]   [Full Text] [Related]  

  • 13. OFT inquiry into prescription-only medicines.
    Orpin P; Sibley R; Harwood D; Padgett C; Hibbert G; Vernon R
    Vet Rec; 2001 Oct; 149(16):498. PubMed ID: 11700933
    [No Abstract]   [Full Text] [Related]  

  • 14. Competition Commission points to complex monopolies in the supply of POMs.
    Vet Rec; 2002 Sep; 151(12):338-9. PubMed ID: 12371688
    [No Abstract]   [Full Text] [Related]  

  • 15. Valuable information regarding generic drugs. Cutting costs by going generic.
    J Am Vet Med Assoc; 2004 Oct; 225(8):1168. PubMed ID: 15521435
    [No Abstract]   [Full Text] [Related]  

  • 16. Advertising prescription only medicines.
    Horrox NE
    Vet Rec; 1998 Sep; 143(13):372. PubMed ID: 9800310
    [No Abstract]   [Full Text] [Related]  

  • 17. FTC workshop explores pet medications: Panelists discuss drug distribution, prescription portability.
    Burns K
    J Am Vet Med Assoc; 2012 Nov; 241(10):1260-1. PubMed ID: 23268538
    [No Abstract]   [Full Text] [Related]  

  • 18. From the supply of POMs to proposed changes in the BVA's structure.
    Vet Rec; 2003 May; 152(19):575-6. PubMed ID: 12762485
    [No Abstract]   [Full Text] [Related]  

  • 19. Draft legislation on supply of POMs: how will it affect you?
    J Small Anim Pract; 2005 Apr; 46(4):207. PubMed ID: 15835242
    [No Abstract]   [Full Text] [Related]  

  • 20. Warning follows reports of growing cascade violations.
    Vet Rec; 2018 Sep; 183(9):282. PubMed ID: 30194117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.